Collaboration aims to identify biomarkers predictive of antibody-drug conjugate (ADC) treatment response using 10x's single cell and spatial platformsPLEASANTON, Calif.,...
BOULDER, Colo., June 17, 2026 /PRNewswire/ -- Igniton is proud to announce that it has been honored with three 2025...
Aarhus, Denmark, 17 June 2026 – NMD Pharma A/S, a clinical-stage biotechnology company dedicated to developing novel therapies to restore...
Introduces key products including an integrated brain imaging analysis solution for Alzheimer's disease treatment decision-makingExpands partnering efforts with global pharmaceutical...
Introduces key products including an integrated brain imaging analysis solution for Alzheimer's disease treatment decision-makingExpands partnering efforts with global pharmaceutical...
LOS ANGELES, June 16, 2026 /PRNewswire/ -- Nervonik, a clinical-stage medical device company developing next-generation peripheral nerve stimulation (PNS) technologies,...
LOS ANGELES, June 16, 2026 /PRNewswire/ -- Nervonik, a clinical-stage medical device company developing next-generation peripheral nerve stimulation (PNS) technologies,...
The new 'virtual biopsy' model predicts brain activity, therapy response, and side effects in patients with up to 3x greater...
The $400,000 prize honors five researchers who developed the first medical device to generate a human sense through a direct...
Harvard neuroscientist tells the D.C. Circuit that expanding marijuana access without fully addressing documented public health risks could have far...
RIYADH, Saudi Arabia, June 14, 2026 (GLOBE NEWSWIRE) -- At HLTH Europe 2026 in Amsterdam, taking place from June 15...
Rhapsido demonstrated statistically significant and clinically meaningful symptom control in twice as many patients vs placebo1, with favorable safety profile...
Cebranopadol is an investigational, first-in-class dual-NMR agonist in development for acute and chronic pain as well as opioid use disorderFive...
Dr. Quirk brings more than 20 years of neuroscience drug discovery and development experience to lead Relmada’s sepranolone program, building...
New UCSF study, published today in Nature Neuroscience, identifies a destructive cellular process that weakens artery walls and could help...
New UCSF study, published today in Nature Neuroscience, identifies a destructive cellular process that weakens artery walls and could help...
Builds on positive Phase I safety data and represents a key value-inflection milestone for the CompanyAdvances a potentially disease-modifying approach...
First partnership announced under Verge Labs' platform-first model; Tenacia will apply Verge's AI platform and proprietary multimodal human tissue data...
New products support sleep quality, recovery, and skin vitality through advanced quantum-enhanced formulationsBOULDER, Colo., June 9, 2026 /PRNewswire/ -- Igniton,...
Acquisition Expands 10x Genomics' Capabilities in Proteomics PLEASANTON, Calif., June 9, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the...